E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers O > Headlines for Oncology Therapeutics Network > News item
Published on 5/20/2005 in the Prospect News Bank Loan Daily.

Oncology Therapeutics gets $300 million revolver

By Sara Rosenberg

New York, May 20 - Oncology Therapeutics Network closed on a new $300 million senior secured revolving credit facility, according to a new release.

CIT Healthcare, a unit of CIT Group Inc., provided the financing.

The revolver was obtained in connection with Equity Partners LLC's acquisition of Oncology Therapeutics Network from Bristol-Myers Squibb Co.

Oncology Therapeutics Network is a San Francisco-based oncology services company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.